Squarepoint’s Intercure INCR Stock Holding History

Squarepoint’s Portfolio INCR Stock Details INCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,254	Closed	-$15.8K	–	4749
2025 Q1	$15.8K	Sell	2,254 -33	-1%	-$267	﹤0.01%	4450
2024 Q4	$18.3K	Buy	+2,287	New	+$18K	﹤0.01%	4940

Other funds holding INCR

Ibex Investors Denver, Colorado $194M AUM 23.58% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return

MCM

Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

RWM

Revisor Wealth Management Akron, Ohio $416M AUM 25.24% 1-Year Est. Return

Quent Capital New York $1.63B AUM 27.42% 1-Year Est. Return

Squarepoint's INCR Position: Q2 2025 in Review

Squarepoint sold out of Intercure (INCR) in Q2 2025, closing a stake of 2,254 shares — an estimated $15.8K sold.

Squarepoint first reported a position in INCR in Q4 2024 and held it in 2 quarters. The position peaked at $18.3K in Q4 2024. 19 funds tracked by Wall St. Rank hold INCR as of Q2 2025.

Squarepoint reported no remaining Intercure position as of Q2 2025 after selling out during the quarter.
Squarepoint sold 2,254 Intercure shares in Q2 2025, an estimated $15.8K.
Squarepoint first reported a position in Intercure in Q4 2024 and held it in 2 quarters.
Squarepoint's Intercure position peaked at $18.3K in Q4 2024.
19 funds tracked by Wall St. Rank held Intercure as of Q2 2025.

Based on Squarepoint's 13F filing for Q2 2025, filed 14 Aug 2025.